We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$8.18B
AUM Growth
+$1B
Cap. Flow
+$26.1M
Cap. Flow %
0.32%
Top 10 Hldgs %
59.27%
Holding
1,129
New
115
Increased
553
Reduced
336
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 8.58%
2 Financials 5.02%
3 Communication Services 2.18%
4 Healthcare 1.89%
5 Consumer Discretionary 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXS icon
801
Plexus
PLXS
$6.97B
$295K ﹤0.01%
+982
New +$256K
QTEC icon
802
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.61B
$295K ﹤0.01%
+882
New +$253K
EXPD icon
803
Expeditors International
EXPD
$23.4B
$295K ﹤0.01%
1,808
+98
+6% +$15.2K
MIDD icon
804
Middleby
MIDD
$5.86B
$294K ﹤0.01%
1,710
+14
+0.8% +$2.11K
ALC icon
805
Alcon
ALC
$32.8B
$293K ﹤0.01%
4,370
-101
-2% -$7.07K
PPL
806
PPL Corp
PPL
$26.6B
$292K ﹤0.01%
8,044
+2,171
+37% +$80.2K
FICO icon
807
Fair Isaac
FICO
$28.5B
$292K ﹤0.01%
244
+3
+1% +$3.36K
UGI icon
808
UGI
UGI
$7.87B
$291K ﹤0.01%
8,420
+1,384
+20% +$48.9K
UCTT
809
Ultra Clean Holdings
UCTT
$4.11B
$289K ﹤0.01%
+2,029
New +$179K
XBI icon
810
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$289K ﹤0.01%
1,827
-112
-6% -$15.1K
DMAC icon
811
DiaMedica Therapeutics
DMAC
$378M
$289K ﹤0.01%
+41,012
New +$252K
VGIT icon
812
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
$288K ﹤0.01%
4,884
SYBT icon
813
Stock Yards Bancorp
SYBT
$2.38B
$287K ﹤0.01%
3,758
ADC icon
814
Agree Realty
ADC
$9.64B
$285K ﹤0.01%
+3,765
New +$285K
RSPT icon
815
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.5B
$285K ﹤0.01%
+4,421
New +$254K
IWO icon
816
iShares Russell 2000 Growth ETF
IWO
$14.9B
$285K ﹤0.01%
723
NTRA icon
817
Natera
NTRA
$37.6B
$284K ﹤0.01%
+1,048
New +$223K
VMI icon
818
Valmont Industries
VMI
$9.81B
$284K ﹤0.01%
+492
New +$247K
JBSS icon
819
John B. Sanfilippo & Son
JBSS
$930M
$284K ﹤0.01%
3,303
+256
+8% +$20.2K
VECO icon
820
Veeco
VECO
$3.09B
$283K ﹤0.01%
+3,738
New +$213K
CACI icon
821
CACI
CACI
$9.97B
$283K ﹤0.01%
610
-16
-3% -$8.17K
RS icon
822
Reliance Steel & Aluminium
RS
$19.6B
$282K ﹤0.01%
+756
New +$276K
ARMK icon
823
Aramark
ARMK
$14.8B
$282K ﹤0.01%
+4,960
New +$245K
CP icon
824
Canadian Pacific Kansas City
CP
$81.4B
$282K ﹤0.01%
3,251
+36
+1% +$3.08K
ONC
825
BeOne Medicines Ltd
ONC
$33.1B
$282K ﹤0.01%
988
+82
+9% +$24.2K

Similar funds

Ballentine Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Ballentine Partners held 1,129 positions worth $8.18B, up 14% from $7.18B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Ballentine Partners's Q2 2026 filing shows 115 new, 553 increased, 336 reduced and 51 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 16,992 shares worth $1.54M. The largest sale was Vanguard Total Stock Market ETF, an estimated $30.8M.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 6.9% a quarter earlier, followed by Financials and Communication Services.

  • Ballentine Partners's largest Q2 2026 buy was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 16,992 shares worth $1.54M.
  • Ballentine Partners added most to iShares Core MSCI EAFE ETF in Q2 2026, an estimated $10.5M increase.
  • Ballentine Partners's biggest Q2 2026 reduction was Vanguard Total Stock Market ETF, cutting an estimated $30.8M.
  • Ballentine Partners fully exited ExxonMobil in Q2 2026, selling an estimated $9.92M.
  • Ballentine Partners's ten largest holdings make up 59% of its $8.18B portfolio in Q2 2026.
  • Ballentine Partners opened 115 new positions and closed 51 in Q2 2026.
  • Ballentine Partners's portfolio value rose 14% quarter-over-quarter to $8.18B.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.